Diagnostic enzymes are a crucial component of medical diagnostics, playing a vital role in the detection and monitoring of various diseases and health conditions. These specialized enzymes are used in diagnostic tests to measure specific biomarkers or to facilitate biochemical reactions that indicate the presence of certain diseases or abnormalities in the body.
The global diagnostic enzymes market is anticipated to increase by USD 1.2 billion till 2029 at an average annual growth of 4.1 percent as per the latest market estimates.
This comprehensive industry report provides market estimates and forecasts, accompanied by a detailed examination of the type, product type, application, and region aspects. It delivers a quantitative analysis of the market, empowering stakeholders to leverage existing market opportunities. Furthermore, the report identifies key segments for potential opportunities and strategies, drawing insights from market trends and the approaches of leading competitors.
The global baby bottle market has been extensively analyzed by categorizing it according to various sub-segments in order to provide accurate forecasts of industry size and assess trends within specific areas.
The global market for diagnostic enzymes can be segmented by type: clinical enzymes, molecular enzymes. In 2022, the molecular enzymes segment made up the largest share of revenue generated by the diagnostic enzymes market.
Diagnostic enzymes market is further segmented by product type: acid phosphatase (AP), alanine aminotransferase (ALT), amylase, Bst polymerase (LAMP enzyme), lyophilized polymerase, creatine kinase (CK), glucose oxidase/glucose dehydrogenase, hot start Taq polymerase, lactate oxidase, M-MLV reverse transcriptase, T7 RNA polymerase, Taq polymerase, others.
Based on application, the diagnostic enzymes market is segmented into: autoimmune diseases, cardiology, diabetes, infectious diseases, nephrology, oncology, others. The oncology segment is estimated to account for the largest share of the global diagnostic enzymes market.
On the basis of region, the diagnostic enzymes market also can be divided into: Asia-Pacific, Europe, North America, Rest of the World (RoW). North America held the highest share in the global diagnostic enzymes market. However, Asia-Pacific is forecast to register the highest CAGR during the forecast period 2023 - 2029.
The report also provides analysis of the key companies of the industry and their detailed company profiles including Aldevron, L.L.C. (Danaher Corporation), Amano Enzyme Inc., Ampliqon A/S, Codexis, Inc., Creative BioMart, Inc. dba Creative Enzymes, EKF Diagnostics Holdings plc, Enzo Life Sciences, Inc., F. Hoffmann-La Roche AG, Kaneka Eurogentec S.A., Merck KGaA, Promega Corporation, Sekisui Diagnostics, LLC, Solis BioDyne OU, Takara Bio Inc., Thermo Fisher Scientific Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
Why Choose This Report
Gain a reliable outlook of the global diagnostic enzymes market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
Market Segments Covered in Global Diagnostic Enzymes Industry Analysis:
i.) Type
- Clinical enzymes
- Molecular enzymes
ii.) Product type
- Acid phosphatase (AP)
- Alanine aminotransferase (ALT)
- Amylase
- Bst polymerase (LAMP enzyme)
- Lyophilized polymerase
- Creatine kinase (CK)
- Glucose oxidase/glucose dehydrogenase
- Hot start Taq polymerase
- Lactate oxidase
- M-MLV reverse transcriptase
- T7 RNA polymerase
- Taq polymerase
- Others
iii.) Application
- Autoimmune diseases
- Cardiology
- Diabetes
- Infectious diseases
- Nephrology
- Oncology
- Others
iv.) Region
- Asia-Pacific
- Europe
- North America
- Rest of the World (RoW)
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
1.1 Description
1.2 Objectives of The Study
1.3 Market Segment
1.4 Years Considered for The Report
1.5 Currency
1.6 Key Target Audience
PART 2. RESEARCH METHODOLOGY
2.1 Primary Research
2.2 Secondary Research
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
4.1 Introduction
4.2 Drivers
4.3 Restraints
PART 5. GLOBAL DIAGNOSTIC ENZYMES MARKET BY TYPE
5.1 Clinical enzymes
5.2 Molecular enzymes
PART 6. GLOBAL DIAGNOSTIC ENZYMES MARKET BY PRODUCT TYPE
6.1 Acid phosphatase (AP)
6.2 Alanine aminotransferase (ALT)
6.3 Amylase
6.4 Bst polymerase (LAMP enzyme)
6.5 Lyophilized polymerase
6.6 Creatine kinase (CK)
6.7 Glucose oxidase/glucose dehydrogenase
6.8 Hot start Taq polymerase
6.9 Lactate oxidase
6.10 M-MLV reverse transcriptase
6.11 T7 RNA polymerase
6.12 Taq polymerase
6.13 Others
PART 7. GLOBAL DIAGNOSTIC ENZYMES MARKET BY APPLICATION
7.1 Autoimmune diseases
7.2 Cardiology
7.3 Diabetes
7.4 Infectious diseases
7.5 Nephrology
7.6 Oncology
7.7 Others
PART 8. GLOBAL DIAGNOSTIC ENZYMES MARKET BY REGION
8.1 Asia-Pacific
8.2 Europe
8.3 North America
8.4 Rest of the World (RoW)
PART 9. COMPANY PROFILES
9.1 Aldevron, L.L.C. (Danaher Corporation)
9.2 Amano Enzyme Inc.
9.3 Ampliqon A/S
9.4 Codexis, Inc.
9.5 Creative BioMart, Inc. dba Creative Enzymes
9.6 EKF Diagnostics Holdings plc
9.7 Enzo Life Sciences, Inc.
9.8 F. Hoffmann-La Roche AG
9.9 Kaneka Eurogentec S.A.
9.10 Merck KGaA
9.11 Promega Corporation
9.12 Sekisui Diagnostics, LLC
9.13 Solis BioDyne OU
9.14 Takara Bio Inc.
9.15 Thermo Fisher Scientific Inc.
DISCLAIMER
Executive Summary
Azoth Analytics has released a research report titled "Global Medical Device Regulatory Affairs Market (2024 Edition)" which provides a complete analysis of the Global Medical Device Regulatory Affairs industry in terms of market segmentation By Type (Diagnostic, Thera...
The PC Diagnostic Tool Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers/pl...
The Molecular Biology Enzymes Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactu...
Overview of the Global Metastatic Melanoma Diagnostic Market:
The report discusses everything a marketer requires before investing in the global Metastatic Melanoma Diagnostic Market during the forecast period 2023-...
Diagnostic enzymes are a crucial component of medical diagnostics, playing a vital role in the detection and monitoring of various diseases and health conditions. These specialized enzymes are used in diagnostic tests to measure specific biomarkers or to facilitate biochemical reactions that indicat...
Overview of the Global Remote Ultrasound Diagnostic System Market:
The report discusses everything a marketer requires before investing in the global Remote Ultrasound Diagnostic System Market during the forecast pe...
Asia Pacific medical device market will grow by 8.4% annually with a total addressable market cap of $2.06 trillion over 2023-2032, driven by the prevalence of infectious diseases as well as the increasing prevalence of chronic diseases, technological innovation, and penetration of healthcare insura...
Europe medical device market was valued at $144.4 billion in 2022 and will grow by 4.7% annually over 2022-2032, driven by the prevalence of infectious diseases as well as the increasing prevalence of chronic diseases, technological innovation, and penetration of healthcare insurance.
Highlig...
North America medical device market is projected to grow by 3.9% annually in the forecast period and reach $ 282.3 billion by 2032, driven by the prevalence of infectious diseases as well as the increasing prevalence of chronic diseases, technological innovation, and penetration of healthcare insura...
Global medical device market will reach $882.3 billion by 2032, growing by 5.5% annually over 2022-2032 owing to aging population worldwide, the prevalence of infectious diseases as well as the increasing prevalence of chronic diseases, technological innovation, and penetration of healthcare insuran...